Clinical Trials Directory

Trials / Completed

CompletedNCT05778968

Etco2 Levels on the End-tidal Concentration of Sevoflurane

The Effect of Different Etco2 Levels on the End-tidal Concentration of Sevoflurane in Patients Undergoing Laparoscopic Cholecystectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Not accepted

Summary

he assessment of adequate levels of anaesthesia traditionally relies not only on a patient's movement but also on the hemodynamic response (or both) to a surgical stimulus

Detailed description

Currently a derivative of MAC namely, end tidal partial pressure (FET) displayed on the work station as concentration , maybe an alternative useful measure of the anaesthetic effect of an inhaled anaesthetic agent . Many pharmacological factors have been associated with alterations in MAC and Mac derivatives such as nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and anesthetics. However, few studies have focused on physiological factors, such as hypercarbia or hypocarbia. A correlation has been found between Paco2 and Etco2 in ventilated patients with healthy lungs. Some authors have suggested that Etco2 could be considered appropriate for estimating Paco2 even in critical patients. Knowledge of the effects of Paco2 on end tidal concentration of sevoflurane among patients undergoing laparoscopic cholecystectomy may help anaesthesiologists titrate sevoflurane carefully and precisely during different mechanical ventilation settings to avoid dose-dependent hypotension, impaired cardiac contractility, and hypothermia caused by excessive anaesthetic depth of sevoflurane.

Conditions

Interventions

TypeNameDescription
PROCEDURElow etco2Etco2 levels will be adjusted at levels ranging between 25 mm Hg and 30 mm Hg
PROCEDUREnormal etco2Etco2 levels will be adjusted at levels ranging between 31 mm Hg and 40 mm Hg
PROCEDUREhigh etco2Etco2 levels will be adjusted at levels ranging between 41 mm Hg and 45 mm Hg

Timeline

Start date
2023-02-01
Primary completion
2024-06-01
Completion
2024-07-29
First posted
2023-03-22
Last updated
2024-07-30

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05778968. Inclusion in this directory is not an endorsement.